Author: chc

11/08/2016

Report from the Coalition Executive Director

CHC-offLabel2

10/31/2016

Kamp to Urge FDA to Provide Clear Guidance on Off-label Communication at November Hearing

10/27/2016

Jenkins to Speak at CHC’s D.C. Meeting

CHC_general1

10/25/2016

Coalition Commentary: How Information Flows … or Doesn’t

10/17/2016

Kamp: Pharma Needs to Step up to Stem Opioid Abuse

CHC_FDA-Regulatory Images2

10/06/2016

CMS Clarifies Sunshine Act CME Exclusion

CHC_FDA-Regulatory Images1

10/03/2016

OPDP’s Abrams: Enforcement Still a Priority, Despite Decrease in Letters

09/29/2016

Purple Strategies’ Haynes to Keynote at CHC Member Meeting in D.C.

CHC_FDA-Regulatory Images1

09/15/2016

OPDP’s Second Enforcement Letter in Two Weeks Targets Investigational Drug